Aehr Test Systems has had a remarkable month — up 61% to $117.18 — but the rally is arriving alongside a cluster of insider sales and a short base that is shrinking rather than pressing into the move.
The most telling dynamic this week is the divergence between price action and short positioning. Short interest has fallen roughly 10.5% over the past week to 14.6% of the free float — still elevated in absolute terms, but clearly moving lower as the stock rips higher. That looks less like a short squeeze and more like orderly covering: bears are exiting into strength, not being forced out. The borrow market supports that read. Availability is ample at nearly 494% of short interest — meaning there are roughly five shares available to borrow for every one currently shorted — and cost to borrow remains negligible at 0.56%. There is no mechanical pressure on remaining shorts. Options positioning adds a nuance: the put/call ratio is running just above its 20-day average at 1.01, barely a fifth of a standard deviation above the mean. That is effectively neutral — options traders are neither hedging aggressively nor chasing calls into the rally.
The earnings reaction data is the hardest number in this note. After the most recent print in July, the stock jumped 29% the next day and gained 45% over the following five days. That is an extraordinary post-earnings move, and it explains much of the one-month price action. The next scheduled print is October 5 — still nearly two months away — so the current positioning partly reflects digestion of that beat rather than fresh positioning ahead of a catalyst.
The insider picture complicates the bullish narrative. The C-suite and board have been active sellers throughout the rally. On August 4, an independent director sold 20,000 shares worth roughly $2.2 million at around $108. The same day, a Vice President sold across two tranches. On July 27, selling was coordinated across five executives simultaneously — the CEO, COO, CTO, and two EVPs all booked gains at $77.48, before the stock pushed another 50% higher. Net insider sales over the past 90 days total around $5.7 million. None of this is necessarily alarming — pre-planned selling programmes are common after a big run — but the breadth and consistency of the insider supply is worth noting when the stock is trading above the mean analyst price target of $115. That target is now essentially at-the-money, based on data through mid-July, and several of the analyst actions in the underlying dataset predate the July earnings catalyst by months, making precise Street conviction harder to gauge.
Institutional interest has picked up in a way that mirrors the momentum. BlackRock added 372,000 shares to reach 8.2% of the company. Jane Street built a new 5% position of 1.37 million shares. T. Rowe Price and Vanguard each added material new stakes in the June quarter. That kind of broad institutional inflow into a small-cap semi equipment name — concentrated exposure to silicon carbide wafer-level burn-in — signals genuine conviction from larger allocators, even as the valuation has stretched. The trailing PE now trades above 100x, and EV/EBITDA is running above 107x, both up sharply on the week as the price moved faster than any earnings revision.
Among close peers, the week was mixed. FORM gained 7.6% on the day, COHU rose 6.8%, and TER added 4% — so there was genuine sector tailwind. But LSCC dropped 8.6% on the week, underscoring that the semiconductor equipment space is not uniformly bid. AEHR's 6.6% weekly gain sits above the peer median, consistent with a stock still enjoying post-earnings momentum rather than simply being carried by the sector.
What to watch next: the October 5 earnings date will be the clearest test of whether the silicon carbide demand story that drove the July beat is durable — and whether the short base, now below 14.6% of float but still meaningfully elevated, continues to deflate ahead of it or rebuilds if revenue expectations moderate.
See the live data behind this article on ORTEX.
Open AEHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
